The HIV 1 & 2 Antibodies Test by CMIA Method is a blood test used to detect antibodies against HIV-1 and HIV-2 viruses. It helps identify possible HIV infection and is commonly used for screening and diagnosis as advised by healthcare professionals.
1.HIV 1 & 2 Antibodies (CMIA Qualitative)
Detects antibodies against Human Immunodeficiency Virus type 1 and type 2 using the CMIA method for HIV screening.
Also known as: HIV Antibody Test, HIV Screening Test, HIV 1 & 2 Test, HIV CMIA Test
The HIV 1 & 2 Antibodies Test by CMIA Method detects antibodies produced by the body in response to infection with Human Immunodeficiency Virus (HIV) types 1 and 2.
HIV affects the immune system by targeting certain cells that help the body fight infections. Early detection through testing allows timely medical guidance, monitoring, and appropriate care.
The CMIA (Chemiluminescent Microparticle Immunoassay) method is a laboratory technique used for accurate detection of HIV antibodies in blood samples.
The HIV 1 & 2 Antibodies Test is a qualitative blood test that checks whether antibodies against HIV-1 and HIV-2 are present in the blood.
The test result is generally reported as:
Doctors may recommend an HIV Antibodies Test to:
The test may be advised if you:
Benefits of the HIV 1 & 2 Antibodies Test:
An HIV test may be recommended for:
Testing decisions should always be based on medical advice and individual circumstances.
No special preparation is required for the HIV 1 & 2 Antibodies Test.
Before the test:
| Parameter | Normal range |
|---|---|
| HIV 1 & 2 Antibodies (CMIA Qualitative) | Non-Reactive / Reactive |
| Note | A non-reactive result means HIV antibodies were not detected at the time of testing. If testing is performed soon after possible exposure, your doctor may recommend repeat testing depending on the situation. |
| A reactive result requires additional confirmatory testing as recommended by healthcare guidelines. |
Reference ranges can differ between labs. Your report shows the range used by the lab.
It is a blood test that detects antibodies produced against HIV-1 and HIV-2 viruses.
CMIA stands for Chemiluminescent Microparticle Immunoassay, a laboratory method used to detect antibodies in blood samples.
No, fasting is not required for an HIV 1 & 2 Antibodies Test.
A non-reactive result means HIV antibodies were not detected in the sample at the time of testing.
| Test name | HIV 1 & 2 Antibodies Test by CMIA Method |
|---|---|
| Location | Rohtak |
| Sample type | Blood |
| Number of parameters | 1 |
| Home sample collection | Available |
| Fasting | Not required |
| Report time | Within 24–48 hours |
| Recommended age | 5–99 years |
| Suitable for | Male & Female |
A reactive result means HIV antibodies were detected. Additional confirmatory testing is required before diagnosis.
The report time depends on the laboratory, but results are usually available within 24–48 hours.
No, HIV tests may not detect infection immediately after exposure. The timing of testing depends on the type of test and individual circumstances.
Home sample collection availability depends on the diagnostic service provider and location.
